产品介绍
猫白血病是猫常见的非创伤性致死疾病,是由猫白血病病毒和猫肉瘤病毒引起的恶性肿瘤性传染病。主要特征是恶性淋巴肿瘤、骨髓性白血病以及变性性胸腺萎缩和非再生性贫血等,其中对猫最严重的是恶性淋巴肿瘤。幼猫易感性高,随年龄增长易感性降低。
|
产品名称
|
类型
|
货号
|
来源
|
建议使用
|
应用
|
|
FLV66
|
rAg
|
|
E.coli
|
包被/标记
|
EIA、LF
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Rat CD26/DPP4 Recombinant Antibody , APC|抗大鼠CD26/DPP4重组抗体,APC(靶标:大鼠CD26(二肽基肽酶IV)) |
135 |
| Anti-Human Calreticulin/CALR Recombinant Antibody , APC|抗人钙网蛋白/CALR重组抗体,APC(靶标:人钙网蛋白) |
405 |
| Mouse IgA Recombinant Isotype Control Antibody, APC|小鼠IgA重组同型对照抗体,APC(靶标:小鼠免疫球蛋白A) |
345 |
| Anti-Human CD34 Recombinant Antibody, APC|抗人CD34重组抗体,APC(靶标:人CD34) |
397 |
| Anti-Human CD34 Recombinant Antibody, APC|抗人CD34重组抗体,APC(靶标:人CD34) |
459 |
| Anti-Mouse CD34 Recombinant Antibody , APC|抗小鼠CD34重组抗体,APC(靶标:小鼠CD34) |
198 |
| Anti-Human CD38 Recombinant Antibody , APC|抗人CD38重组抗体,APC(靶标:人CD38) |
261 |
| Anti-Human CD38 Recombinant Antibody, APC|抗人CD38重组抗体,APC(靶标:人CD38) |
205 |
| Anti-Human CD38 Recombinant Antibody, APC|抗人CD38重组抗体,APC(靶标:人CD38) |
125 |
| Anti-Human CD38/ADPRC 1 Recombinant Antibody, APC|抗人CD38/ADPRC 1重组抗体,APC(靶标:人CD38) |
262 |
| Anti-Human CD38/ADPRC1 Recombinant Antibody, APC|抗人CD38/ADPRC1重组抗体,APC(靶标:人CD38) |
429 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody, APC|抗人CD30/TNFRSF8重组抗体,APC(靶标:人CD30(TNFRSF8)) |
482 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody , APC|抗人CD30/TNFRSF8重组抗体,APC(靶标:人CD30(TNFRSF8)) |
238 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody, APC|抗人CD30/TNFRSF8重组抗体,APC(靶标:人CD30(TNFRSF8)) |
369 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody , APC|抗人CD30/TNFRSF8重组抗体,APC(靶标:人CD30(TNFRSF8)) |
268 |
| Anti-Human A2AR/ADORA2A Recombinant Antibody , APC|抗人A2AR/ADORA2A重组抗体,APC(靶标:人腺苷A2a受体) |
458 |
| Anti-Human CTGF/CCN2 Recombinant Antibody , APC|抗人CTGF/CCN2重组抗体,APC(靶标:人结缔组织生长因子) |
230 |
| Anti-Human EPHA2 Recombinant Antibody , APC|抗人EPHA2重组抗体,APC(靶标:人Eph受体A2) |
424 |
| Anti-Human EPHA3 Recombinant Antibody , APC|抗人EPHA3重组抗体,APC(靶标:人Eph受体A3) |
161 |
| Anti-Human IL12A/IL-12 p35/NKSF1 Recombinant Antibody , APC|抗人IL12A/IL-12 p35/NKSF1重组抗体,APC(靶标:人IL-12 p35亚基) |
164 |